Jin T, Nordberg G F, Nordberg M
Pharmacol Toxicol. 1987 May;60(5):345-9. doi: 10.1111/j.1600-0773.1987.tb01524.x.
Kidney cells were isolated from rats pretreated by daily subcutaneous doses of cadmium metallothionein (CdMT: 0.05-0.2 mg Cd/kg X 5) and from non-pretreated rats. Upon exposure to CdCl2 in vitro (0-200 micrograms Cd/ml), a concentration dependent decrease in viability was observed in the non-pretreated cells, while no such decrease occurred in the pretreated cells indicating that these cells were more resistant to the toxic action of cadmium. There was a higher in vitro uptake of Cd+2 and an increased metallothionein (MT) concentration in the pretreated cells (compared to non-pretreated cells). Subcellular distribution studies revealed that Cd was mainly recovered in the "cytosol" fraction. The higher total cadmium uptake in pretreated cells corresponded to an increase of Cd in "cytosol" and "nuclear" fractions. This observation may be explained by MT-binding of Cd in the cells and is in accordance with a possible protective effect of induced MT in the pretreated cells. In order to assess whether pretreatment-induced tolerance to cadmium toxicity--indicated by the cellular studies--could also be observed in vivo, some whole animal experiments were also performed. A dose-related proteinuria was observed in non-pretreated rats after a single subcutaneous administration of 109Cd-MT at doses of 0.05 and 0.4 mg Cd/kg. Urinary total Cd, 109Cd and MT was also increased in a dose-related fashion. Cadmium concentrations in kidney were dose related and reached 19 micrograms/g wet weight. In contrast, in animals repeatedly pretreated with CdMT according to 1), no proteinuria was observed after administration of the same single doses of 109CdMT. Total Cd. 109Cd and particularly MT-concentrations in urine were lower in such pretreated animals than in in non-pretreated ones in spite of the accumulation of higher tissue concentrations of total Cd (up to 80 micrograms/g). The pretreatment was thus shown to prevent some of the acute nephrotoxicity of CdMT, possibly by means of induction of MT synthesis.
从每日皮下注射镉金属硫蛋白(CdMT:0.05 - 0.2 mg Cd/kg×5)预处理的大鼠以及未预处理的大鼠中分离肾细胞。体外暴露于CdCl₂(0 - 200微克Cd/ml)时,未预处理的细胞中观察到活力呈浓度依赖性下降,而预处理的细胞中未出现这种下降,表明这些细胞对镉的毒性作用更具抗性。预处理的细胞中Cd²⁺的体外摄取更高,金属硫蛋白(MT)浓度增加(与未预处理的细胞相比)。亚细胞分布研究表明,镉主要在“胞质溶胶”部分中回收。预处理细胞中总镉摄取量较高对应于“胞质溶胶”和“细胞核”部分中镉的增加。这一观察结果可能是由于细胞中镉与MT结合所致,并且与预处理细胞中诱导的MT可能具有的保护作用一致。为了评估细胞研究表明的预处理诱导的对镉毒性的耐受性在体内是否也能观察到,还进行了一些整体动物实验。在未预处理的大鼠单次皮下注射剂量为0.05和0.4 mg Cd/kg的¹⁰⁹Cd - MT后,观察到剂量相关的蛋白尿。尿中总镉、¹⁰⁹Cd和MT也呈剂量相关增加。肾脏中的镉浓度与剂量相关,达到19微克/克湿重。相比之下,在按照1)用CdMT反复预处理的动物中,给予相同单剂量的¹⁰⁹CdMT后未观察到蛋白尿。尽管组织中总镉浓度更高(高达80微克/克),但这种预处理动物尿中的总镉、¹⁰⁹Cd,尤其是MT浓度低于未预处理的动物。因此,预处理显示可预防CdMT的一些急性肾毒性,可能是通过诱导MT合成来实现的。